Literature DB >> 24113711

Pellino3 targets RIP1 and regulates the pro-apoptotic effects of TNF-α.

Shuo Yang1, Bingwei Wang, Lisa S Tang, Jakub Siednienko, John J Callanan, Paul N Moynagh.   

Abstract

Tumour necrosis factor-α (TNF) can activate NF-κB to induce pro-inflammatory genes but can also stimulate the caspase cascade to promote apoptosis. Here we show that deficiency of the ubiquitin E3 ligase, Pellino3, sensitizes cells to TNF-induced apoptosis without inhibiting the NF-κB pathway. Suppressed expression of Pellino3 leads to enhanced formation of the death-induced signalling complex, complex II, in response to TNF. We show that Pellino3 targets RIP1, in a TNF-dependent manner, to inhibit TNF-induced complex II formation and caspase 8-mediated cleavage of RIP1 in response to TNF/cycloheximide co-stimulation. Pellino3-deficient mice also show increased sensitivity to TNF-induced apoptosis and greatly increased lethality in response to TNF administration. These findings define Pellino3 as a novel regulator of TNF signalling and an important determining factor in dictating whether TNF induces cell survival or death.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24113711     DOI: 10.1038/ncomms3583

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  23 in total

1.  Targeting CAND1 promotes caspase-8/RIP1-dependent apoptosis in liver cancer cells.

Authors:  Zhihui Che; Fuchen Liu; Wenli Zhang; Mary McGrath; Daisen Hou; Ping Chen; Chunhua Song; Dongqin Yang
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

Review 2.  RIP kinases: key decision makers in cell death and innate immunity.

Authors:  F Humphries; S Yang; B Wang; P N Moynagh
Journal:  Cell Death Differ       Date:  2014-08-22       Impact factor: 15.828

Review 3.  The roles of Pellino E3 ubiquitin ligases in immunity.

Authors:  Paul N Moynagh
Journal:  Nat Rev Immunol       Date:  2014-01-21       Impact factor: 53.106

Review 4.  Necroptosis and its role in inflammation.

Authors:  Manolis Pasparakis; Peter Vandenabeele
Journal:  Nature       Date:  2015-01-15       Impact factor: 49.962

Review 5.  E3 ubiquitin ligases Pellinos as regulators of pattern recognition receptor signaling and immune responses.

Authors:  Andrei E Medvedev; Michael Murphy; Hao Zhou; Xiaoxia Li
Journal:  Immunol Rev       Date:  2015-07       Impact factor: 12.988

6.  Autophagy-dependent PELI3 degradation inhibits proinflammatory IL1B expression.

Authors:  Annika Klara Giegerich; Laura Kuchler; Lisa Katharina Sha; Tilo Knape; Heinrich Heide; Ilka Wittig; Christian Behrends; Bernhard Brüne; Andreas von Knethen
Journal:  Autophagy       Date:  2014-10-30       Impact factor: 16.016

7.  Ligase Pellino3 Regulates Macrophage Action and Survival in Response to VSV Infection in RIG-I-Dependent Path.

Authors:  Patryk Reniewicz; Anna Kula; Edyta Makuch; Michał Ochnik; Tomasz Lipiński; Jakub Siednienko
Journal:  Oxid Med Cell Longev       Date:  2021-07-01       Impact factor: 6.543

8.  Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy.

Authors:  Guozhen Cui; Luchen Shan; Lin Guo; Ivan Keung Chu; Guohui Li; Quan Quan; Yun Zhao; Cheong Meng Chong; Zaijun Zhang; Pei Yu; Maggie Pui Man Hoi; Yewei Sun; Yuqiang Wang; Simon MingYuen Lee
Journal:  Sci Rep       Date:  2015-06-03       Impact factor: 4.379

Review 9.  RIPK protein kinase family: Atypical lives of typical kinases.

Authors:  Gregory D Cuny; Alexei Degterev
Journal:  Semin Cell Dev Biol       Date:  2020-07-27       Impact factor: 7.727

10.  Inhibition of lethal inflammatory responses through the targeting of membrane-associated Toll-like receptor 4 signaling complexes with a Smad6-derived peptide.

Authors:  Youn Sook Lee; Jin Seok Park; Su Myung Jung; Sang-Doo Kim; Jun Hwan Kim; Jae Young Lee; Kyeong Cheon Jung; Mizuko Mamura; Sangho Lee; Seong-Jin Kim; Yoe-Sik Bae; Seok Hee Park
Journal:  EMBO Mol Med       Date:  2015-05       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.